Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

EyePoint Pharmaceuticals (EYPT) Revenue: 2010-2018

Historic Revenue for EyePoint Pharmaceuticals (EYPT) over the last 8 years, with Sep 2018 value amounting to $486,000.

  • EyePoint Pharmaceuticals' Revenue rose 26.23% to $486,000 in Q3 2018 from the same period last year, while for Sep 2018 it was $2.2 million, marking a year-over-year decrease of 70.85%. This contributed to the annual value of $3.0 million for FY2018, which is 60.72% down from last year.
  • As of Q3 2018, EyePoint Pharmaceuticals' Revenue stood at $486,000, which was down 32.03% from $715,000 recorded in Q2 2018.
  • In the past 5 years, EyePoint Pharmaceuticals' Revenue registered a high of $25.3 million during Q3 2014, and its lowest value of $100,000 during Q4 2017.
  • Its 3-year average for Revenue is $980,091, with a median of $486,000 in 2018.
  • As far as peak fluctuations go, EyePoint Pharmaceuticals' Revenue surged by 4,139.03% in 2014, and later tumbled by 98.33% in 2017.
  • Over the past 5 years, EyePoint Pharmaceuticals' Revenue (Quarterly) stood at $521,000 in 2014, then rose by 0.96% to $526,000 in 2015, then soared by 1,035.17% to $6.0 million in 2016, then plummeted by 98.33% to $100,000 in 2017, then rose by 26.23% to $486,000 in 2018.
  • Its last three reported values are $486,000 in Q3 2018, $715,000 for Q2 2018, and $928,000 during Q1 2018.